Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Nature Genetics|June 15, 2021
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetesCatherine C Robertson, Jamie R J Inshaw, Suna Onengut-Gumuscu, et al.
The Pharmacogenomics Journal|May 26, 2018
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsJohn C Taylor, Tim Bongartz, Jonathan Massey, et al.
Annals of the Rheumatic Diseases|December 13, 2012
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritisMaša Umiċeviċ Mirkov, Jing Cui, Sita H Vermeulen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 4, 2023
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal DiseasesAnne R Bass, Eliza Chakravarty, Elie A Akl, et al.
Arthritis Care & Research|January 4, 2023
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal DiseasesAnne R Bass, Eliza Chakravarty, Elie A Akl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African AmericansPravitt Gourh, Elaine F Remmers, Steven E Boyden, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicryPravitt Gourh, Sarah A Safran, Theresa Alexander, et al.
Annals of the Rheumatic Diseases|February 5, 2026
Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosisUrvashi Kaundal, Pei-Suen Tsou, Mousumi Sahu, et al.
Pageof 14